个人科研网厅 | | 帮助
高级检索
当前位置： 首页 > 详情页

Prospective Comparison of Four Plasma Testing Platforms for T790M and Effectiveness of Osimertinib in Chinese NSCLC Patients

| 认领 | 导出 | |

文献详情

资源类型：
WOS体系：

收录情况： ◇ SCIE

作者：
Wu, Y.[1,2] * ; Chen, Y.[3] ; Wu, G.[4] ; Zhang, H.[5] ; Lu, Y.[6] ; Cheng, Y.[7] ; Hu, Y.[8] ; Liang, Z.[9,14] ; Wang, J.[10,11] ; Ying, J.[11,12] ; Liu, W.[13] ; Zhang, X.[1,2] ; Liang, Z.[9,14] ;
单位： [1]Guangdong Gen Hosp, Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China [2]Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China [3]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Oncol, Wuhan, Hubei, Peoples R China [4]Huazhong Univ Sci & Technol, Union Hosp, Canc Ctr, Tongji Med Coll, Wuhan, Hubei, Peoples R China [5]Fourth Mil Med Univ, Tangdu Hosp, Dept Oncol, Xian, Shaanxi, Peoples R China [6]Sichuan Univ, West China Hosp, Canc Ctr, Dept Thorac Oncol, Chengdu, Sichuan, Peoples R China [7]Jilin Prov Canc Hosp, Dept Oncol, Changchun, Jilin, Peoples R China [8]Hubei Canc Hosp, Dept Oncol, Wuhan, Hubei, Peoples R China [9]Sichuan Univ, West China Hosp, Dept Resp & Crit Care Med, Chengdu, Sichuan, Peoples R China [10]Chinese Acad Med Sci, Canc Hosp, Natl Canc Ctr, Dept Med Oncol, Beijing, Peoples R China [11]Peking Union Med Coll, Beijing, Peoples R China [12]Chinese Acad Med Sci, Canc Hosp, Natl Canc Ctr, Dept Pathol, Beijing, Peoples R China [13]Sichuan Univ, West China Hosp, Dept Pathol, Chengdu, Sichuan, Peoples R China [14]Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Pathol, Beijing, Peoples R China
出处：
DOI： 10.1016/j.jtho.2018.08.1561
ISSN：

关键词： T790M detection NSCLC

语种：
外文
WOS：
中科院(CAS)分区：
出版当年[2017]版：
大类 | 2 区 医学
小类 | 2 区 肿瘤学 2 区 呼吸系统
最新[2025]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学 1 区 呼吸系统
JCR分区：
出版当年[2016]版：
Q1 ONCOLOGY Q1 RESPIRATORY SYSTEM
最新[2023]版：
Q1 ONCOLOGY Q1 RESPIRATORY SYSTEM

影响因子： 最新[2023版] 最新五年平均 出版当年[2016版] 出版当年五年平均 出版前一年[2015版] 出版后一年[2017版]

第一作者：
第一作者单位： [1]Guangdong Gen Hosp, Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China [2]Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China
推荐引用方式(GB/T 7714)：
Wu Y.,Chen Y.,Wu G.,et al.Prospective Comparison of Four Plasma Testing Platforms for T790M and Effectiveness of Osimertinib in Chinese NSCLC Patients[J].JOURNAL OF THORACIC ONCOLOGY.2018,13(10):S867-S867.doi:10.1016/j.jtho.2018.08.1561.
APA：
Wu, Y.,Chen, Y.,Wu, G.,Zhang, H.,Lu, Y....&Liang, Z..(2018).Prospective Comparison of Four Plasma Testing Platforms for T790M and Effectiveness of Osimertinib in Chinese NSCLC Patients.JOURNAL OF THORACIC ONCOLOGY,13,(10)
MLA：
Wu, Y.,et al."Prospective Comparison of Four Plasma Testing Platforms for T790M and Effectiveness of Osimertinib in Chinese NSCLC Patients".JOURNAL OF THORACIC ONCOLOGY 13..10(2018):S867-S867

相关文献

[1]Detection of EGFR T790M Mutations by Four Testing Platforms in ctDNA from Chinese Patients with Advanced NSCLC [2]Detection of EGFR T790M Mutations by Four Testing Platforms in ctDNA from Chinese Patients with Advanced NSCLC [3]Detection of EGFR T790M in Asia-Pacific patients (pts) with EGFR mutation-positive advanced non-small cell lung cancer (NSCLC): Circulating tumour (ct) DNA analysis across 3 platforms [4]HIF-1α和LOX在非小细胞癌中的表达及其临床意义 [5]联合检测在非小细胞肺癌中鉴别诊断的价值 [6]Immunotherapy for NSCLC with oncogenic driver variants [7]MicroRNA-152 targets ADAM17 to suppress NSCLC progression [8]EMP-1 promotes tumorigenesis of NSCLC through PI3K/AKT pathway [9]Gross Tumor Volume Contouring Variations in Radiation Therapy of Non-Small Cell Lung Cancer [10]Thoracic Organs at Risk (OARs) Contouring Variations and Consensus in Radiation Therapy for Non-Small Cell Lung Cancer

资源点击量：589 今日访问量：0 总访问量：441 更新日期：2025-06-01 建议使用谷歌、火狐浏览器 常见问题

版权所有：重庆聚合科技有限公司 渝ICP备12007440号-3 地址：重庆市两江新区泰山大道西段8号坤恩国际商务中心16层（401121）